Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design

Abstract An experimental design, the Central Composite, was used for the optimization of a new filler/binder (Xylitab 200®) for direct compression, with aspirin as the model drug. The design consists of four independent variables filler/binder, drug, disintegrant, and compression force) in varying a...

Full description

Saved in:
Bibliographic Details
Published in:Drug development and industrial pharmacy 1997, Vol.23 (10), p.945-950
Main Authors: Cirunay, Jesusa Joyce N., Plaizier-vercammen, Jacqueline A.
Format: Article
Language:English
Subjects:
Analgesics
Biological and medical sciences
General pharmacology
Medical sciences
Neuropharmacology
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3
cites cdi_FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3
container_end_page 950
container_issue 10
container_start_page 945
container_title Drug development and industrial pharmacy
container_volume 23
creator Cirunay, Jesusa Joyce N.
Plaizier-vercammen, Jacqueline A.
description Abstract An experimental design, the Central Composite, was used for the optimization of a new filler/binder (Xylitab 200®) for direct compression, with aspirin as the model drug. The design consists of four independent variables filler/binder, drug, disintegrant, and compression force) in varying amounts, and with crushing strength, friability, weight variation, disintegration time, and dissolution rate as response variables. Multiple regression in the form of a second-order polynomial was used to determine meaningful relationships. In this study, the amounts of compression force and disintegrant played an important role in controlling the response variables.
doi_str_mv 10.3109/03639049709149145
format article
fullrecord <record><control><sourceid>informahealthcare_pasca</sourceid><recordid>TN_cdi_pascalfrancis_primary_2823474</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3109_03639049709149145</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3</originalsourceid><addsrcrecordid>eNp9kEFLwzAUx4MoOKcfwFsOXuuSJm0a9KKbU2G4izt4Kmn6smW0TUkqY356O6eCCIMH7_B-v_cef4QuKblmlMgRYSmThEtBJOV9JUdoQJOYRIlI42M02M2jHkhO0VkIa0JoLJNkgN7mbWdr-6E66xrsDFb4BTZ4aqsK_OjeNiV4bJzHE-tBd3js6tZDCDt6EWyzxGNoOq-qr4kLtgM8gWCXzTk6MaoKcPHdh2gxfXgdP0Wz-ePz-G4Wac5ZF1EuBE2FzGJQLCljYyRVouClBE5YkUEqdUlVmhnNMw1pDDojgtJSpWVhdMGGiO73au9C8GDy1tta-W1OSb7LJv-XTe9c7Z1WBa0q41WjbfgV4yxmXPAeu91jtukjqNXG-arMO7WtnP9x2KErN3_0FaiqW2nlIV-7d9_0qRz48RNfBImv</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Cirunay, Jesusa Joyce N. ; Plaizier-vercammen, Jacqueline A.</creator><creatorcontrib>Cirunay, Jesusa Joyce N. ; Plaizier-vercammen, Jacqueline A.</creatorcontrib><description>Abstract An experimental design, the Central Composite, was used for the optimization of a new filler/binder (Xylitab 200®) for direct compression, with aspirin as the model drug. The design consists of four independent variables filler/binder, drug, disintegrant, and compression force) in varying amounts, and with crushing strength, friability, weight variation, disintegration time, and dissolution rate as response variables. Multiple regression in the form of a second-order polynomial was used to determine meaningful relationships. In this study, the amounts of compression force and disintegrant played an important role in controlling the response variables.</description><identifier>ISSN: 0363-9045</identifier><identifier>EISSN: 1520-5762</identifier><identifier>DOI: 10.3109/03639049709149145</identifier><language>eng</language><publisher>Colchester: Informa UK Ltd</publisher><subject>Analgesics ; Biological and medical sciences ; General pharmacology ; Medical sciences ; Neuropharmacology ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments</subject><ispartof>Drug development and industrial pharmacy, 1997, Vol.23 (10), p.945-950</ispartof><rights>1997 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1997</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3</citedby><cites>FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=2823474$$DView record in Pascal Francis$$Hfree_for_read</backlink></links><search><creatorcontrib>Cirunay, Jesusa Joyce N.</creatorcontrib><creatorcontrib>Plaizier-vercammen, Jacqueline A.</creatorcontrib><title>Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design</title><title>Drug development and industrial pharmacy</title><description>Abstract An experimental design, the Central Composite, was used for the optimization of a new filler/binder (Xylitab 200®) for direct compression, with aspirin as the model drug. The design consists of four independent variables filler/binder, drug, disintegrant, and compression force) in varying amounts, and with crushing strength, friability, weight variation, disintegration time, and dissolution rate as response variables. Multiple regression in the form of a second-order polynomial was used to determine meaningful relationships. In this study, the amounts of compression force and disintegrant played an important role in controlling the response variables.</description><subject>Analgesics</subject><subject>Biological and medical sciences</subject><subject>General pharmacology</subject><subject>Medical sciences</subject><subject>Neuropharmacology</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><issn>0363-9045</issn><issn>1520-5762</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><recordid>eNp9kEFLwzAUx4MoOKcfwFsOXuuSJm0a9KKbU2G4izt4Kmn6smW0TUkqY356O6eCCIMH7_B-v_cef4QuKblmlMgRYSmThEtBJOV9JUdoQJOYRIlI42M02M2jHkhO0VkIa0JoLJNkgN7mbWdr-6E66xrsDFb4BTZ4aqsK_OjeNiV4bJzHE-tBd3js6tZDCDt6EWyzxGNoOq-qr4kLtgM8gWCXzTk6MaoKcPHdh2gxfXgdP0Wz-ePz-G4Wac5ZF1EuBE2FzGJQLCljYyRVouClBE5YkUEqdUlVmhnNMw1pDDojgtJSpWVhdMGGiO73au9C8GDy1tta-W1OSb7LJv-XTe9c7Z1WBa0q41WjbfgV4yxmXPAeu91jtukjqNXG-arMO7WtnP9x2KErN3_0FaiqW2nlIV-7d9_0qRz48RNfBImv</recordid><startdate>1997</startdate><enddate>1997</enddate><creator>Cirunay, Jesusa Joyce N.</creator><creator>Plaizier-vercammen, Jacqueline A.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>IQODW</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>1997</creationdate><title>Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design</title><author>Cirunay, Jesusa Joyce N. ; Plaizier-vercammen, Jacqueline A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Analgesics</topic><topic>Biological and medical sciences</topic><topic>General pharmacology</topic><topic>Medical sciences</topic><topic>Neuropharmacology</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cirunay, Jesusa Joyce N.</creatorcontrib><creatorcontrib>Plaizier-vercammen, Jacqueline A.</creatorcontrib><collection>Pascal-Francis</collection><collection>CrossRef</collection><jtitle>Drug development and industrial pharmacy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cirunay, Jesusa Joyce N.</au><au>Plaizier-vercammen, Jacqueline A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design</atitle><jtitle>Drug development and industrial pharmacy</jtitle><date>1997</date><risdate>1997</risdate><volume>23</volume><issue>10</issue><spage>945</spage><epage>950</epage><pages>945-950</pages><issn>0363-9045</issn><eissn>1520-5762</eissn><abstract>Abstract An experimental design, the Central Composite, was used for the optimization of a new filler/binder (Xylitab 200®) for direct compression, with aspirin as the model drug. The design consists of four independent variables filler/binder, drug, disintegrant, and compression force) in varying amounts, and with crushing strength, friability, weight variation, disintegration time, and dissolution rate as response variables. Multiple regression in the form of a second-order polynomial was used to determine meaningful relationships. In this study, the amounts of compression force and disintegrant played an important role in controlling the response variables.</abstract><cop>Colchester</cop><pub>Informa UK Ltd</pub><doi>10.3109/03639049709149145</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0363-9045
ispartof Drug development and industrial pharmacy, 1997, Vol.23 (10), p.945-950
issn 0363-9045
1520-5762
language eng
recordid cdi_pascalfrancis_primary_2823474
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Analgesics
Biological and medical sciences
General pharmacology
Medical sciences
Neuropharmacology
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
title Optimization of a New Filler/Binder for Direct Compression Using Central Composite Design
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T17%3A08%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-informahealthcare_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Optimization%20of%20a%20New%20Filler/Binder%20for%20Direct%20Compression%20Using%20Central%20Composite%20Design&rft.jtitle=Drug%20development%20and%20industrial%20pharmacy&rft.au=Cirunay,%20Jesusa%20Joyce%20N.&rft.date=1997&rft.volume=23&rft.issue=10&rft.spage=945&rft.epage=950&rft.pages=945-950&rft.issn=0363-9045&rft.eissn=1520-5762&rft_id=info:doi/10.3109/03639049709149145&rft_dat=%3Cinformahealthcare_pasca%3E10_3109_03639049709149145%3C/informahealthcare_pasca%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c443t-1477167982ea35d2ff91a7b4d9e403b8e69cd1a68fc48ce62ec80711da6dbfcb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true